If you or a loved one suffered a vaso-occlusive crisis, stroke, organ damage or death after taking Oxbryta (Voxelotor) for sickle cell disease or sickle cell anemia, you may be entitled to compensation from an Oxbryta lawsuit case or settlement claim.
A team of drug injury attorneys and class action lawyers is investigating potential Oxbryta lawsuit and settlement cases involving individuals who suffered a vaso-occlusive crisis or sickle cell crisis, including stroke, organ damage or death, after taking Oxbryta for sickle cell disease.
Oxbryta (voxelotor) is an oral, once-daily prescription medication (a hemoglobin S polymerization inhibitor) that was used to treat patients with sickle cell disease (SCD) or sickle cell anemia.
Sickle cell disease is a group of inherited blood disorders affecting about 100,000 Americans that changes the shape of hemoglobin, the protein that carries oxygen in red blood cells and causes them to change from being round and flexible to a rigid and sticky sickle or crescent shape, leading to slow or blocked blood flow.
Unfortunately, in September of 2024, the FDA issued a safety recall alert that Oxbryta was being withdrawn/recalled from the market by Pfizer, the manufacturer, due to safety concerns as data indicated that the benefit of Oxbryta did not outweigh the risks. According to the FDA, various clinical trials and/or studies reported a higher rate of vaso-occlusive crisis and more deaths amongst patients with sickle cell disease receiving Oxbryta compared to placebo (i.e., those not receiving Oxbryta).
A vaso-occlusive crisis (sickle cell crisis) is a severely painful medical emergency caused by sickled red blood cells blocking blood flow and oxygen delivery to tissues, potentially causing, among other things, debilitating pain all over the body, including the back, abdomen, chest, and arms, stroke, organ damage and, in some cases, death.
Oxbryta Sickle Cell Crisis Lawsuit: Overview
- What Is The Oxbryta Sickle Cell Crisis Lawsuit About?
- What Is Oxbryta (Voxelotor)?
- What Is Sickle Cell Disease (Sickle Cell Anemia)?
- What Is a Sickle Cell Crisis (Vaso-Occlusive Crisis)?
- Was There An Oxbryta Recall?
- Who May Qualify For an Oxbryta Recall Lawsuit or Settlement?
- What Companies Have Been Sued Over Oxbryta?
- What Are Possible Signs or Symptoms of a Sickle Cell Crisis (VOC)?
- What Are The Stages of A Sickle Cell Crisis?
- Are There Medical Treatments For a Sickle Cell Crisis?
- Can I Recover Compensation From an Oxbryta Sickle Cell Lawsuit?
- Is There A Deadline To File an Oxbryta Sickle Cell Lawsuit?
- Request A Free Case Review From An Oxbryta Recall Injury Lawyer
Oxbryta Recall Lawsuit & Settlement Cases
Oxbryta recall lawsuit and settlement cases potentially being investigated include claims involving individuals who, after taking Oxbryta (voxelotor) for sickle cell anemia, suffered from a vaso-occlusive crisis or sickle cell crisis and/or other injury, including:
- Vaso-occlusive crisis (VOC)
- Increased vaso-occlusive crises
- Sickle cell crisis
- Sickling crisis
- Acute chest syndrome
- Stroke
- Blood clots
- Organ damage
- Kidney failure
- Hepatic failure
- Severe pain
- Ischaemia
- Restriction of blood supply
- Necrosis (tissue or bone death)
- Arthritis
- Priapism
- Dactylitis (inflammation of fingers or toes)
- Vision loss
- Pulmonary hypertension
- Splenic sequestration
- Sleep apnea
- Leg ulcers
- Jaundice
- Infections
- Pneumonia
- Hospitalization
- Death
- Other Oxbryta injury lawsuit cases
If you or someone you love suffered from a vaso-occlusive crisis or sickle cell crisis after taking Oxbryta, you may be eligible to recover monetary compensation from an Oxbryta sickle cell lawsuit or settlement case.
Oxbryta Sickle Cell Lawsuit Complaints
Oxbryta lawsuits have been filed by individuals with sickle cell disease seeking to recover money damages for injuries suffered after using Oxbryta. According to the Oxbryta lawsuit complaints, plaintiffs suffered from sickle cell crisis or vaso-occlusive crisis and related complications (such as stroke, organ damage, death, etc.) after taking Oxbryta.
Plaintiffs in the Oxbryta lawsuits have alleged, among other things, defendants knew or should have known about the health risks of Oxbryta but did not provide an adequate warning.
The Oxbryta lawsuit complaints have asserted legal claims for, among other things, negligence, strict liability (design defect and failure to warn), breach of express and implied warranty, unjust enrichment, and violation of various state consumer protection statutes.
Companies Sued For Oxbryta Injury
Defendants named in the Oxbryta injury lawsuit cases have included pharmaceutical companies involved in the manufacturing, research, development, marketing, distribution, sale, and release for use to the general public of Oxbryta, including:
- Pfizer, Inc.
- Global Blood Therapeutics, Inc.
Vaso-Occlusive Crisis (VOC) Signs & Symptoms
Signs and symptoms of vaso-occlusive crisis (VOC) can include:
- Severe pain
- Back pain
- Chest pain
- Pain in leg(s)
- Pain in arm(s) or feet
- Dull, sharp or throbbing pain
- Acute chest syndrome
- Swelling of hands
- Swelling of feet
- Numbness
- Tingling
- Burning sensations
- Abnormal feeling in skin (paresthesia)
- Extreme fatigue
- Fever
- Infections
- Other sickle cell crisis symptoms or signs
Procedures and tests used by physicians to diagnose a vaso-occlusive crisis or sickle cell crisis can include a patient history, physical exam, laboratory tests (including complete blood count, reticulocyte count, urinalysis, comprehensive metabolic panel, kidney function tests, liver function test, etc.), and imaging tests (e.g., CT scans), among others.
A vaso-occlusive crisis generally consist of four phases which last about 5 to 7 days (though not all patients experience all four phases and not all patients experience the phases in the same order with the same frequency, severity, or duration). Phase 1 of a sickle cell crisis (known as the prodromal phase) is characterized by low-intensity aching pain, with possible tingling or numbness, and it typically lasts about three days or so. Phase 2 of a sickle cell crisis (called the initial phase) is characterized by a rapid increase in acute pain associated with the beginning stages of tissue death. Phase 3 of a vaso-occlusive crisis (referred to as the established phase) is characterized by constant severe pain (and often fever) as a result of continued tissue death and the body’s inflammatory response to dying tissue and often lasts three to five days. Phase 4 of a vaso-occlusive crisis (known as the resolving phase) is characterized by the resolution of the crisis which can last a few days or more.
Sickle Cell Crisis Treatment
Treatments for sickle cell crisis can include pain relief medications (such as analgesics), supplemental oxygen, hyperbaric oxygen therapy, warm compresses, IV fluids to hydrate the body, blood transfusion, cognitive behavioral therapy, and antibiotics for infections, among other treatments.
Compensation For Oxbryta Injury Claims
Plaintiffs who bring Oxbryta sickle cell disease lawsuits may be able to recover compensation for injuries suffered, including money damages for losses incurred as a result of using Oxbryta, such as:
- Compensatory damages for pain and suffering
- Loss of wages or earnings due to missed work
- Loss of future earning capacity
- Medical care expenses incurred or to be incurred
- Other out of pocket expenses
- Loss of quality or enjoyment of life
- Mental anguish/emotional distress
- Loss of consortium
- Other possible Oxbryta damages
Certain family and loved ones of Oxbryta users who may have died after using Oxbryta may be able to recover financial compensation from an Oxbryta wrongful death lawsuit or settlement claim.
Oxbryta wrongful death lawsuit damages might include, among other things, pecuniary losses suffered by a surviving spouse or next of kin of the deceased family member, such as loss of money or income, benefits, goods, services, and loss of society (i.e., the mutual benefits that each family member receives from the other’s continued existence, including love, affection, care, attention, companionship, comfort, guidance, and protection).
Time Is Limited To File An Oxbryta Recall Lawsuit
Deadlines known as statutes of limitation and statutes of repose can limit the amount of time that individuals have to file an Oxbryta injury lawsuit to try to recover compensation for injuries they may have suffered (e.g., sickle cell crisis or vaso-occlusive crisis, stroke, organ damage, kidney failure, or death) after using Oxbryta to treat sickle cell disease.
This means that if an Oxbryta recall lawsuit claim is not filed before the appropriate deadline or limitations period, the injured party may be barred from ever pursuing litigation or taking legal action regarding their Oxbryta injury claim. That is why it is important to connect with an Oxbryta recall injury lawyer or attorney as soon as possible.
If you or a loved one have suffered sickle cell crisis, stroke, organ damage, kidney failure, or death after taking Oxbryta for sickle cell anemia, you may be entitled to recover compensation from an Oxbryta lawsuit case or settlement claim. Contact a drug injury lawyer to request a free case review.
*If you or a loved one are experiencing health issues, side effects or complications after taking a prescription drug or medication, we urge you to promptly consult with your doctor or physician for an evaluation.
**The listing of a company (e.g., Pfizer) or product (e.g., Oxbryta) is not meant to state or imply that the company acted illegally or improperly or that the product is unsafe or defective; rather only that an investigation may be, is or was being conducted to determine whether legal rights have been violated.
***The use of any trademarks, tradenames or service marks is solely for product identification and/or informational purposes.
Fill out the form to request a free attorney review.